Profile
Full Name
Foghorn Therapeutics Inc.Ticker Symbol
FHTXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
October 23, 2020Indexes
Not includedWebsite
http://foghorntx.comEmployees
112Key Details
Price
$3.57(-0.56%)
Market cap
$198.54M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$22.60M(-33.83% YoY)
Annual EPS
-$1.58(+32.48% YoY)
PE ratio
-
Next earnings date
May 6, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Foghorn Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 7, 25 HC Wainwright & Co.
BuyJan 30, 25 B. Riley Securities
BuyDec 17, 24 HC Wainwright & Co.
BuyDec 16, 24 Jefferies
BuySep 24, 24 Morgan Stanley
Equal-WeightSep 3, 24 Jefferies
BuyAug 19, 24 Evercore ISI Group
OutperformAug 12, 24 HC Wainwright & Co.
BuyAug 9, 24 Wedbush
OutperformMay 7, 24 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Foghorn Therapeutics?
- Does Foghorn Therapeutics pay dividends?
- What sector is Foghorn Therapeutics in?
- What industry is Foghorn Therapeutics in?
- What country is Foghorn Therapeutics based in?
- When did Foghorn Therapeutics go public?
- Is Foghorn Therapeutics in the S&P 500?
- Is Foghorn Therapeutics in the NASDAQ 100?
- Is Foghorn Therapeutics in the Dow Jones?
- When was Foghorn Therapeutics's last earnings report?
- When does Foghorn Therapeutics report earnings?
- Should I buy Foghorn Therapeutics stock now?
What is the ticker symbol for Foghorn Therapeutics?
The ticker symbol for Foghorn Therapeutics is NASDAQ:FHTX
Does Foghorn Therapeutics pay dividends?
No, Foghorn Therapeutics does not pay dividends
What sector is Foghorn Therapeutics in?
Foghorn Therapeutics is in the Healthcare sector
What industry is Foghorn Therapeutics in?
Foghorn Therapeutics is in the Biotechnology industry
What country is Foghorn Therapeutics based in?
Foghorn Therapeutics is headquartered in United States
When did Foghorn Therapeutics go public?
Foghorn Therapeutics's initial public offering (IPO) was on October 23, 2020
Is Foghorn Therapeutics in the S&P 500?
No, Foghorn Therapeutics is not included in the S&P 500 index
Is Foghorn Therapeutics in the NASDAQ 100?
No, Foghorn Therapeutics is not included in the NASDAQ 100 index
Is Foghorn Therapeutics in the Dow Jones?
No, Foghorn Therapeutics is not included in the Dow Jones index
When was Foghorn Therapeutics's last earnings report?
Foghorn Therapeutics's most recent earnings report was on Mar 6, 2025
When does Foghorn Therapeutics report earnings?
The next expected earnings date for Foghorn Therapeutics is May 6, 2025
Should I buy Foghorn Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions